197 related articles for article (PubMed ID: 32342115)
21. Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses.
Cox HM; Tough IR; Woolston AM; Zhang L; Nguyen AD; Sainsbury A; Herzog H
Cell Metab; 2010 Jun; 11(6):532-42. PubMed ID: 20519124
[TBL] [Abstract][Full Text] [Related]
22. Beneficial metabolic effects of recurrent periods of beta-cell rest and stimulation using stable neuropeptide Y1 and glucagon-like peptide-1 receptor agonists.
Tanday N; Lafferty RA; Flatt PR; Irwin N
Diabetes Obes Metab; 2022 Dec; 24(12):2353-2363. PubMed ID: 35848461
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II Type 1 Receptor-Dependent GLP-1 and PYY Secretion in Mice and Humans.
Pais R; Rievaj J; Larraufie P; Gribble F; Reimann F
Endocrinology; 2016 Oct; 157(10):3821-3831. PubMed ID: 27447725
[TBL] [Abstract][Full Text] [Related]
24. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
25. Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models.
Forbes S; Stafford S; Coope G; Heffron H; Real K; Newman R; Davenport R; Barnes M; Grosse J; Cox H
Diabetes; 2015 Nov; 64(11):3763-71. PubMed ID: 26239054
[TBL] [Abstract][Full Text] [Related]
26. Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion.
Panaro BL; Yusta B; Matthews D; Koehler JA; Song Y; Sandoval DA; Drucker DJ
Mol Metab; 2020 Jul; 37():100990. PubMed ID: 32278655
[TBL] [Abstract][Full Text] [Related]
27. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.
Evans S; Pamuklar Z; Rosko J; Mahaney P; Jiang N; Park C; Torquati A
Surg Endosc; 2012 Apr; 26(4):1086-94. PubMed ID: 22044971
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms underlying the prokinetic effects of endogenous glucagon-like peptide-1 in the rat proximal colon.
Nakamori H; Iida K; Hashitani H
Am J Physiol Gastrointest Liver Physiol; 2021 Dec; 321(6):G617-G627. PubMed ID: 34643099
[TBL] [Abstract][Full Text] [Related]
29. Differences in hormone localisation patterns of K and L type enteroendocrine cells in the mouse and pig small intestine and colon.
Cho HJ; Kosari S; Hunne B; Callaghan B; Rivera LR; Bravo DM; Furness JB
Cell Tissue Res; 2015 Feb; 359(2):693-698. PubMed ID: 25378285
[TBL] [Abstract][Full Text] [Related]
30. The Noncaloric Sweetener Rebaudioside A Stimulates Glucagon-Like Peptide 1 Release and Increases Enteroendocrine Cell Numbers in 2-Dimensional Mouse Organoids Derived from Different Locations of the Intestine.
van der Wielen N; Ten Klooster JP; Muckenschnabl S; Pieters R; Hendriks HF; Witkamp RF; Meijerink J
J Nutr; 2016 Dec; 146(12):2429-2435. PubMed ID: 27798332
[TBL] [Abstract][Full Text] [Related]
31. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults.
Chambers ES; Viardot A; Psichas A; Morrison DJ; Murphy KG; Zac-Varghese SE; MacDougall K; Preston T; Tedford C; Finlayson GS; Blundell JE; Bell JD; Thomas EL; Mt-Isa S; Ashby D; Gibson GR; Kolida S; Dhillo WS; Bloom SR; Morley W; Clegg S; Frost G
Gut; 2015 Nov; 64(11):1744-54. PubMed ID: 25500202
[TBL] [Abstract][Full Text] [Related]
32. The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo.
Panaro BL; Tough IR; Engelstoft MS; Matthews RT; Digby GJ; Møller CL; Svendsen B; Gribble F; Reimann F; Holst JJ; Holst B; Schwartz TW; Cox HM; Cone RD
Cell Metab; 2014 Dec; 20(6):1018-29. PubMed ID: 25453189
[TBL] [Abstract][Full Text] [Related]
33. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
[TBL] [Abstract][Full Text] [Related]
34. Important Role of the GLP-1 Axis for Glucose Homeostasis after Bariatric Surgery.
Larraufie P; Roberts GP; McGavigan AK; Kay RG; Li J; Leiter A; Melvin A; Biggs EK; Ravn P; Davy K; Hornigold DC; Yeo GSH; Hardwick RH; Reimann F; Gribble FM
Cell Rep; 2019 Feb; 26(6):1399-1408.e6. PubMed ID: 30726726
[TBL] [Abstract][Full Text] [Related]
35. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).
Blanco AM; Bertucci JI; Valenciano AI; Delgado MJ; Unniappan S
Horm Behav; 2017 Jul; 93():62-71. PubMed ID: 28506816
[TBL] [Abstract][Full Text] [Related]
36. SCFAs strongly stimulate PYY production in human enteroendocrine cells.
Larraufie P; Martin-Gallausiaux C; Lapaque N; Dore J; Gribble FM; Reimann F; Blottiere HM
Sci Rep; 2018 Jan; 8(1):74. PubMed ID: 29311617
[TBL] [Abstract][Full Text] [Related]
37. Role of peptide YY in 5-fluorouracil-induced reduction of dietary intake.
Sakai H; Kai Y; Takase K; Sato K; Kimura M; Tabata S; Yaegashi M; Sato F; Yomoto T; Narita M
Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):753-9. PubMed ID: 27130783
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide 1 and peptide YY are in separate storage organelles in enteroendocrine cells.
Cho HJ; Robinson ES; Rivera LR; McMillan PJ; Testro A; Nikfarjam M; Bravo DM; Furness JB
Cell Tissue Res; 2014 Jul; 357(1):63-9. PubMed ID: 24842049
[TBL] [Abstract][Full Text] [Related]
39. Dynamin regulates L cell secretion in human gut.
Sun EW; Matusica D; Wattchow DA; McCluskey A; Robinson PJ; Keating DJ
Mol Cell Endocrinol; 2021 Sep; 535():111398. PubMed ID: 34274446
[TBL] [Abstract][Full Text] [Related]
40. Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice.
Boland BB; Mumphrey MB; Hao Z; Townsend RL; Gill B; Oldham S; Will S; Morrison CD; Yu S; Münzberg H; Rhodes CJ; Trevaskis JL; Berthoud HR
Mol Metab; 2019 Jul; 25():64-72. PubMed ID: 31126840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
